• PDF: Delivered by email usually within 48 UK business hours.

Health Discovery Corporation (HDVY) - Pharmaceuticals & Healthcare
Deals and Alliances Profile

  • Publication Date:March 2011
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:65

Health Discovery Corporation (HDVY) - Pharmaceuticals & Healthcare Deals and Alliances Profile

Health Discovery Corporation (HDVY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Health Discovery Corporation (HDC) is a publicly held company specialized in medicine and biomarker discovery. The company mainly focuses on the gene based tests for the detection of various types of cancers such as prostate cancer, colon cancer, leukemia and AIDS. It also develops products for image analysis such as digital mammography. HDC develops products using its key technologies including support vector machine (SVM), recursive feature elimination (RFE), fractal genomic modeling (FGM) and independent validations. The company distributes its products in the US and to many other parts of the world. It has partnered with NYC Pancreatic cancer center to develop Molecular Diagnostic Test. HDC has signed a deal with Smart Personalized Medicine, LLC, to develop new Breast Cancer Prognostic Test using Support Vector Machine (SVM) Technology of HDC. HDC is headquartered in Georgia, the US.

Health Discovery Corporation (HDVY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you an in-depth data and trend analysis of the company's mergers and acquisitions (M&A) and financings. The report provides detailed information on M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions registered by the company over a five year period. The report portrays detailed comparative data on the number of deals and their value subdivided by deal types, markets, and regions, besides highlighting the company's major recent financial deals.

Data presented in this report was derived from GlobalData's proprietary in-house Pharmaceuticals and Healthcare eTrack deals database and primary and secondary research.

Scope

  • Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information on the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information on the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region for North America, Europe, the Middle East and Africa and South and Central America.
  • Deals by Market - Chart and table showing information on the number of deals and value reported by the company, by market.
  • Major Recent Deals - Information on the company's major recent financial deals. Each such deal has a brief summary, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key Competitors - A list of key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements.

  • The profile analyzes the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divesture strategy

  • Deals are presented from the company's core business segments' perspective to help you understand its corporate strategy

Access detailed information about the company's recent financial deals that enables you to understand the key deals which have shaped the company

  • Major recent deals are presented in detail, which provides information on each deal's brief summary, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company to identify potential customers and suppliers.

  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and their biographies and key competitors.

Stay up to date on the major developments affecting the company

  • Recent developments in the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research.

  • Key elements such as break up of deals by categories and information on detailed major deals are incorporated in the profile to assist your academic or business research needs.

This report covers the following industry codes:
SIC Code: 2835
NAICS Code: 325413

  • Table of Contents
    • Table of Contents
    • L ist of Tables
  • List of Figures
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare Deals By Type, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Medical Devices Deals, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deal Details
    • Health Discovery And Smart Personalized Medicine Enters Into Licensing Agreement With Quest Diagnostics
    • Health Discovery Signs An Agreement With Quest Diagnostics
    • Health Discovery Enters Into An Agreement With Smart Personalized Medicine
    • Ciphergen Biosystems Enters Into Licensing Agreement With Health Discovery
    • Clarient Signs An Agreement With Health Discovery
    • Partnerships
    • Health Discovery Signs An Agreement With Abbott Laboratories
    • Health Discovery Enters Into Co-Development Agreement With DCL Medical
    • Clarient Enters Into An Agreement With Health Discovery
    • Licensing Agreements
    • Health Discovery Enters Into Licensing Agreement With Pfizer
    • Health Discovery Enters Into Licensing Agreement With Bruker Daltonics
    • Health Discovery Enters Into Licensing Agreement With Epigenomic
    • Clarient Extends Licensing Agreement With Health Discovery
    • Equity Offering
    • Health Discovery Raises $1.65 Million From Exercise Of Warrants
    • Health Discovery Completes Private Placement Of $2.56 Million
    • Health Discovery Completes Private Placement Of $2.1 Million
    • Health Discovery Completes Private Placement Of $2.99 Million
    • Key Competitors
    • Key Employees
    • Locations And Subsidiaries
    • Head Office
    • Recent Developments
    • Corporate Communications
    • Mar 01, 2011: Health Discovery Corporation Announces Resignation Of Thomas Gallagher As President, COO And General Counsel
    • Oct 26, 2010: Health Discovery Corporation Appoints Thomas Gallagher As President, COO And General Counsel
    • Nov 30, 2009: Health Discovery Corporation Names Tom Gallagher To Head Global Intellectual Property Strategies
    • May 04, 2009: Health Discovery Corporation Names Scott Tobin As President And General Counsel
    • Legal and Regulatory
    • Jul 06, 2007: Health Discovery Corporation Settles Patent Infringement Suit Against Ciphergen Biosystems, Inc
    • Nov 28, 2006: Health Discovery Corporation Obtains Consent Judgment In Patent Lawsuit Against Equbits Llc
    • Jun 27, 2006: Health Discovery Corporation Files Patent Infringement Suits; Hdc Also Announced That An Outside Board Member Would Acquire Equity On The Open Market In Support Fo The Companys Strategic Direction
    • Product News
    • Nov 30, 2005: Health Discovery Corporation Applies For U.S. And Foreign Patent Protection Of Prostate Disease Biomarkers Identified Using Svm Technology
    • Nov 28, 2005: Health Discovery Corporation Announces Significant Expansion Of Its Intellectual Property Portfolio
    • Oct 19, 2009: Health Discovery Corporation Announces Additional Issued Patents And Notices Of Allowance To Its Intellectual Property Portfolio
    • Oct 11, 2006: Health Discovery Corporation Receives Pioneering U.S. Patent For Its Renowned Rfe-Svm Technology
    • Oct 08, 2008: Health Discovery Corporations New Prostate Cancer Test Is Ready For Commercialization Following Successful Completion Of Final Clinical Trials
    • Sep 28, 2007: Health Discovery Corporation Receives Notice Of Allowance Of U.S. Patent Application Covering Feature Selection Methods Using Svms
    • Sep 24, 2009: Health Discovery Corporation's Dr. Stephen Barnhill Tells Participants At London Conference That Biomarkers Patented By His Company Promise To Revolutionize The Field Of Molecular Diagnostics
    • Sep 20, 2005: Health Discovery Corporation Announces New Patent Issuance
    • Sep 20, 2004: Health Discovery Corporation Announces The Filing Of Additional Patents For Newly Discovered Biomarkers In Hiv Infection And New Biomarker Discovery Tools
    • Sep 07, 2004: New Patent Expands Health Discovery Corporation's Intellectual Property Portfolio For Support Vector Machines
    • Aug 20, 2007: Health Discovery Corporation Receives Notice Of Acceptance Of Australian Patent Application Covering Biomarker Selection Using Svms
    • Aug 12, 2008: Health Discovery Corporation's Newest U.S. Patent Covers Svm-Based Analysis Of Medical Images
    • Aug 09, 2004: Health Discovery Corporation Announces Filing Of Patent Applications For New Biomarker Discovery In Hiv-Infection, Leukemia And Downs Syndrome
    • Aug 07, 2008: New Prostate Cancer Test Is Ready For Commercialization Following Successful Completion Of Final Clinical Trials
    • Aug 06, 2007: Health Discovery Corporation Announces Allowance Of New U.S. Patent And Issuance Of A European Patent Covering Fractal Genomics Modeling Technology
    • Aug 04, 2008: Health Discovery Corporation Inks Agreement With Patent Profit International For Monetization Of Patent Portfolio
    • Aug 03, 2004: Health Discovery Corporation Acquires Rights To Patent Portfolio That Includes Issued Pioneer Patents On Support Vector Machines
    • Jul 30, 2007: Health Discovery Corporation Announces Allowance Of New U.S. Patent Covering Svm Pre-Processing Methods
    • Jul 14, 2005: Health Discovery Corporation Announces Approval And Issuance Of Multiple Patent Applications Covering Svm Methods
    • Jun 24, 2008: Health Discovery Corporation Announces Successful Phase Ii Clinical Trial Results For New Gene-Based Molecular Diagnostic Test For Prostate Cancer
    • May 16, 2005: Health Discovery Corporation Completes Acquisition Of Valuable Support Vector Machine (Svm) Patent Portfolio And Immediately Initiates Licensing And Product Development Program
    • May 08, 2008: Health Discovery Corporation Announces The Issuance Of Two New U.S. Patents Covering Applications Of Support Vector Machines (Svms)
    • Apr 30, 2008: Health Discovery Corporation Announces Successful Clinical Trial Results For New Molecular Diagnostic Test For Prostate Cancer
    • Apr 26, 2005: Health Discovery Corporation Announces Issuance Of New U.S. Patent Covering Use Of Svms For Processing Multiple Data Sets
    • Apr 04, 2005: Health Discovery Corporation Announces Filing Of Patent Application Covering Methods For Enhancing Accuracy Of Biomarker Discovery
    • Mar 28, 2005: Health Discovery Corporation Announces Approval Of Patent Application Covering Fractal Genomics Modeling (Fgm) Technology
    • Mar 03, 2010: Health Discovery Corporation Applauds American Cancer Society's Decision Against The Use Of The Psa For Routine Prostate Cancer Screening
    • Mar 01, 2005: Health Discovery Corporation Announces Approval Of Patent Application Covering Recursive Feature Elimination (Rfe) In Support Vector Machines (Svm's)
    • Feb 28, 2006: Health Discovery Corporation Receives Notice Of Allowance Of Landmark Patent Application Covering Recursive Feature Elimination (Rfe) In Svm's For Data Mining
    • Feb 23, 2005: Health Discovery Corporation Introduces New Cellular Imaging Technology To Identify Circulating Tumor Cells In The Blood At The Drug Discovery And Technology Leaders Summit
    • Feb 22, 2007: Health Discovery Corporation Files For U.S. And Foreign Patent Protection Of New Prostate Cancer Biomarker Discovery
    • Feb 18, 2010: Health Discovery Corporation Selected As "best & Brightest" Small Cap Company By Mdb Capital Group And Expands Patent Portfolio
    • Feb 16, 2010: Health Discovery Corporation Introducing The Worlds First Mobile Phone App For Melanoma And Other Skin Cancers Using Svm-Based Image Analysis Techniques
    • Feb 09, 2006: Health Discovery Corporation Announces Issuance Of New U.S. Patent Covering Svm-Based Image Analysis Including Digital Mammography
    • Feb 03, 2010: Vermillion Pays Health Discovery Corporation Final Patent Infringement Settlement Payment
    • Jan 13, 2009: Clarient Launches Gene Expression Test For Prostate Cancer
  • Appendix
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer 65
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Key Facts, 2009
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare Deals By Type, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2005 to YTD 2011
    • Health Discovery Corporation, Deals By Therapy Area, 2005 to YTD 2011
    • Health Discovery Corporation, Medical Devices Deals, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2005 to YTD 2011
    • Health Discovery And Smart Personalized Medicine Enters Into Licensing Agreement With Quest Diagnostics
    • Health Discovery Signs An Agreement With Quest Diagnostics
    • Health Discovery Enters Into An Agreement With Smart Personalized Medicine
    • Ciphergen Biosystems Enters Into Licensing Agreement With Health Discovery
    • Clarient Signs An Agreement With Health Discovery
    • Health Discovery Signs An Agreement With Abbott Laboratories
    • Health Discovery Enters Into Co-Development Agreement With DCL Medical
    • Clarient Enters Into An Agreement With Health Discovery
    • Health Discovery Enters Into Licensing Agreement With Pfizer
    • Health Discovery Enters Into Licensing Agreement With Bruker Daltonics
    • Health Discovery Enters Into Licensing Agreement With Epigenomic
    • Clarient Extends Licensing Agreement With Health Discovery
    • Health Discovery Raises $1.65 Million From Exercise Of Warrants
    • Health Discovery Completes Private Placement Of $2.56 Million
    • Health Discovery Completes Private Placement Of $2.1 Million
    • Health Discovery Completes Private Placement Of $2.99 Million
    • Health Discovery Corporation, Key Employees 32
  • List of Figures
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2005 to YTD 2011
    • Health Discovery Corporation, Pharmaceuticals & Healthcare, Medical Devices Deals, 2005 to YTD 2011
+44 20 8816 8548

Ask a question about Health Discovery Corporation (HDVY) - Pharmaceuticals & Healthcare

Enter the characters you see in the picture below
Captcha